Comparing Telerehabilitation and In-Person Physical Therapy to Improve Sexual Function and Reduce Pain in Menopausal Women with Dyspareunia

What this Trial Is About

Researchers are evaluating the effectiveness of a telerehabilitation program compared to face-to-face physiotherapy in improving sexual function, reducing pain, and enhancing quality of life in menopausal women with dyspareunia. The study aims to determine if an asynchronous online telerehabilitation program is not less effective than traditional face-to-face treatment, using tools like the Female Sexual Function Index FSFI, Visual Analogue Scale VAS, and Menopause Specific Quality of Life Questionnaire MENQOL. Secondary goals include assessing combined treatment benefits, vaginal dilator size changes, adverse effects, treatment adherence, and participant satisfaction. Participants will be assigned to one of three groups an online telerehabilitation program called Pelvify Menopause and dyspareunia treatment, a face-to-face physical therapy protocol involving manual therapy and radiofrequency treatment, or a combination of both. Each intervention lasts five weeks, with sessions including explanatory videos or individual physiotherapy visits weekly. All participants will have a face-to-face assessment in the sixth week, followed by telephone check-ins six and twelve months after treatment completion. During the study, participants will complete questionnaires evaluating sexual function, pain levels, and quality of life at baseline, after five weeks, one week post-treatment, and at six and twelve months follow-up. Researchers will also monitor vaginal dilator size changes, adherence to treatment plans, and any adverse effects. The total involvement includes initial treatment, follow-up visits, and long-term telephone monitoring to assess sustained outcomes.

Effectiveness of a Telerehabilitation Program for Improving Sexual Function and Reducing Pain in Menopausal Women